SMEs to Benefit as Seventh Framework Research Programme is Adopted by European Parliament
As to the Commission's objective to increase the participation of Small and Medium Sized Enterprises (SMEs) in FP7 to at least 15%, several new initiatives will be included to make the programme more SME-friendly. Examples of such initiatives include a higher EU-contribution to the total project costs (75% EU-funding per project compared to 50% under FP6), the establishment of an FP7 guarantee fund (resulting in reduced needs for financial checks and bank guarantees), and improved and simplified financial and administrative procedures (including adapted intellectual property regime).
Laurens G. Theunis, Manager of EuropaBio's Emerging Enterprises Council added: "We very much appreciate the efforts of the Commission in making FP7 more accessible to young research-driven companies". Mr. Theunis continued: "Given the instrumental role of biotech SMEs in new product discovery and development, the biotech industry also very much welcomes the growing political support within the Commission for SMEs. It's now up to the Member States to follow and build further towards a more competitive biotech industry at a global level."
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.